599 evaluable patients were enrolled ; 57.3 % received 4L-PEG preparations , 29.5 % 2L-PEG preparations and 13.2 % 2-glasses-solutions ( Na-phosphate/Mg-citrate/Na-picosulphate-containing preparations ) .